BeStock  
Stocks › ADPT

Adaptive Biotechnologies ADPT

US equityMarket cap rank #2143
$29.84 +$1.49 (+5.26%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $30.00 +0.54%
Open$28.57
Prev close$28.35
Day range$28.16 – $29.86
Volume1.43M
Market cap$4.76B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.7%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+33.7%
Worst reaction-18.2%

Stock move on the day after each report

-18.2%2023/Q3+0.5%2023/Q4+2.3%2024/Q1-3.4%2024/Q2+3.4%2024/Q3-3.2%2024/Q4+33.7%2025/Q1+5.8%2025/Q2-11.5%2025/Q3-4.3%2025/Q4+4.7%2026/Q1+7.2%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q229 Jul 2026After Market±17.8%+7.18%Within range
2026/Q15 May 2026After Market±22.6%+4.72%Within range
2025/Q45 Feb 2026After Market±16.1%-4.25%Within range
2025/Q35 Nov 2025After Market±19.4%-11.54%Within range
2025/Q25 Aug 2025After Market±32.4%+5.79%Within range
2025/Q11 May 2025After Market±21.7%+33.70%Bigger than priced
2024/Q411 Feb 2025After Market±21.7%-3.21%Within range
2024/Q37 Nov 2024After Market±25.0%+3.37%Within range
2024/Q21 Aug 2024After Market±20.9%-3.37%Within range
2024/Q17 May 2024After Market±28.3%+2.25%Within range
2023/Q414 Feb 2024After Market±37.3%+0.51%Within range
2023/Q39 Nov 2023After Market±14.0%-18.18%Bigger than priced
2023/Q22 Aug 2023After Market±23.1%-12.44%Within range
2023/Q13 May 2023After Market±18.5%-14.27%Within range
2022/Q414 Feb 2023After Market±17.9%+15.55%Within range
2022/Q33 Nov 2022After Market±21.6%+14.27%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Minimal Residual Disease (MRD)$93.66M 84.1%
  • Immune Medicine$17.66M 15.9%

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$71.55M+21.5% YoY
Operating profit-$15.77M+37.0% YoY
Net profit-$39.94M-56.1% YoY
Diluted EPS-$0.25-47.1% YoY

Revenue, last 8 quarters

$46.4MSep '24$47.5MDec '24$52.4MMar '25$58.9MJun '25$94.0MSep '25$71.7MDec '25$70.9MMar '26$71.6MJun '26

Net profit, last 8 quarters

$-32.1MSep '24$-33.7MDec '24$-29.8MMar '25$-25.6MJun '25$9.5MSep '25$-13.6MDec '25$-20.0MMar '26$-39.9MJun '26

Profitability & balance sheet

Gross margin75.6%
Operating margin-12.2%
Net margin-20.7%
Return on equity-39.6%
Return on assets-11.2%
Return on invested capital-14.9%
Current ratio4.79
Liabilities / assets76.5%
Cash & investments$344.26M
Total debt$401.68M
Net cash (debt)-$57.42M

Discussion

No comments yet — be the first to weigh in on ADPT.

Leave a comment

Scroll to Top